Document Detail

Interleukin-17 and kidney allograft outcome.
MedLine Citation:
PMID:  19545679     Owner:  NLM     Status:  MEDLINE    
Acute rejection episodes (ARE) are important complications that involve the interplay between mechanisms that maintain graft tolerance and promote rejection. The proinflammatory cytokine interleukin-17 (IL-17) has been implicated in many conditions in humans and mice. In kidney transplant patients, the evaluation IL-17 levels has been performed in only a few patients. We performed a cross-sectional study correlating quantitative IL-17 levels and clinical outcomes. PATIENTS AND METHODS: We studied 19 specimens from biopsies performed in patients (n = 19) who received isolated kidney grafts. ARE signs were present in 9 (47%) patients who provide specimens; whereas, 10 (53%) others showed no signs of rejection. Eighteen healthy control sample IL-17 underwent measurement, all of which were performed by an enzyme-linked immunosorbent assay method. We assessed other factors, such as the recipients demographic data, cold ischemia time, HLA mismatches, time elapsed from transplantation to the biopsy, posttransplantation status, antibody panel, donor type, and immunosuppressive treatment. RESULTS: IL-17 levels were clearly increased among samples derived from patients with ongoing rejection (125.7 +/- 27.06 pg/mL) in contrast, to the nonrejection group, (30 +/- 13.32 pg/mL) (P < .05). Healthy controls showed no detectable IL-17 levels. CONCLUSIONS: These findings suggested that IL-17 was important in the pathophysiology of acute kidney rejection.
J C O Crispim; R Grespan; G Martelli-Palomino; D M Rassi; R S Costa; L T Saber; F Q Cunha; E A Donadi
Related Documents :
16008739 - Small vessel disease after heart transplantation: impact of immunologic and nonimmunolo...
8050179 - Cytokine mrna expression in endomyocardial biopsies during acute rejection from human h...
3305819 - Heart allograft rejection under varying immunosuppressive protocols as evaluated by end...
12231369 - Acute vascular rejection is associated with up-regulation of vitronectin receptor (alph...
12352889 - Quantitative detection of t-cell activation markers by real-time pcr in renal transplan...
17699199 - Protocol transplant biopsies: are they really needed?
18813109 - Pd-l1/pd-1 signal deficiency promotes allogeneic immune responses and accelerates heart...
17243569 - Eighteen years of heart transplantation--a single center experience.
20534279 - Prevalence and clinical impact of polyomaviruses ki and wu in lung transplant recipients.
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  Transplantation proceedings     Volume:  41     ISSN:  1873-2623     ISO Abbreviation:  Transplant. Proc.     Publication Date:  2009 Jun 
Date Detail:
Created Date:  2009-06-23     Completed Date:  2009-09-28     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  0243532     Medline TA:  Transplant Proc     Country:  United States    
Other Details:
Languages:  eng     Pagination:  1562-4     Citation Subset:  IM    
Department of Biochemistry and Immunology, School of Medicine of Ribeirão Preto, University of São Paulo, (FMRP-USP), São Paulo, Brazil.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Biological Markers / blood*
Graft Rejection / blood*,  immunology
Immunosuppressive Agents / therapeutic use
Interleukin-17 / blood*
Middle Aged
Reference Values
Reg. No./Substance:
0/Biological Markers; 0/Immunosuppressive Agents; 0/Interleukin-17

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Effect of CYP3A5 Genotype on Renal Allograft Recipients Treated With Tacrolimus.
Next Document:  Clinical Application of Cordyceps sinensis on Immunosuppressive Therapy in Renal Transplantation.